Herbert Loong: Our latest recommendations for NTRK fusion testing and management in lung cancer
Herbert Loong shared on X:
“We have recently published our latest recommendations for NTRK fusion testing and management in lung cancer.”
Source: Herbert Loong/X
NTRK gene fusion testing and management in lung cancer
Authors: Matteo Repetto, Marina Chiara Garassino, Herbert Loong, Fernando Lopez-Rios, Tony Mok, Solange Peters, David Planchard, Sanjay Popat, Erin R. Rudzinski, Alexander Drilon, and Caicun Zhou.
Herbert Loong is an Associate Professor in the Department of Clinical Oncology at The Chinese University of Hong Kong (CUHK), with additional roles as Deputy Medical Director of the Phase 1 Clinical Trials Centre and founder of the Prince of Wales Hospital Adult Sarcoma Multidisciplinary Team.
Dr. Loong has co-founded key organizations like the Asia Pacific Oncology Drug Development Consortium (APODDC) and the Asia Pacific Coalition Against Lung Cancer (APCLC). His involvement in international oncology bodies, including ASCO and IASLC, underscores his commitment to advancing cancer research and treatment on a global scale.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023